Intact Vascular Inc. announced in February that its Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) clinical trial has commenced enrollment. The first patient was treated by Joseph Cardenas, M.D., at Yuma Regional Hospital and the Heart, Lung and Vascular Center in Yuma, Ariz.

Society for Vascular Surgery

IBM at the 2017 Healthcare Information and Management Systems Society Conference and Exhibition (HIMSS17) introduced IBM Watson Imaging Clinical Review, the first cognitive imaging offering from Watson Health. The company also announced the expansion of the Watson Health medical imaging collaborative to 24 organizations worldwide, adding clinical and industry expertise for the worldwide initiative finding ways to use medical imaging to identify and predict the risk of cancer, diabetes and diseases of the eye, brain, breast, heart and related conditions.


March 2, 2017 — Here is the list of the top 20 most popular pieces of content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of February based on website analytics:  

1. FDA Clears First Noninvasive Electro-Anatomical Mapping System

March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc. first-in-class Cobra PzF NanoCoated Coronary Stent System. Coated with a proprietary nano-thin polymer that is designed to be highly biocompatible, the Cobra PzF stent requires a minimum 30-day dual antiplatelet therapy (DAPT) regimen following intervention.[1]

Through participation in the new Interventional Radiology (IR) Registry, interventional radiologists can take steps to improve quality of care and outcomes for patients undergoing image-guided interventional procedures.

Up to 40 percent of emergency room (ER) patients with chest pain can safely go home in a little under 2 hours, using a highly sensitive, newly U.S. Food and Drug Administration (FDA)-approved blood test and a heart health scoring system. These findings were drawn from an international study led by Henry Ford Health System.

March 1, 2017 — BTG plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance has been granted to the Ekos Control Unit 4.0.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now